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Background:  There has been extensive debate about outcomes following coronary artery bypass graft surgery (CABG) with or without cardiopulmonary 
bypass (CPB-CABG or OPCABG). Patients with poor ventricular function are especially prone to hemodynamic and systemic complications. This study aims 
to review our experience with low-ejection fraction patients undergoing coronary revascularization with or without CPB.
Methods:  Data was collected prospectively on all patients with left ventricular ejection fraction (LVEF) 30% undergoing isolated coronary 
revascularization at The Methodist Hospital from 01/2004 to 09/2010.
Results:  A total of 295 consecutive patients were identified with poor LV function (192 CPB-CABG and 103 OPCABG) and included for analysis. 
Baseline and postoperative parameters are shown in table below. Both groups had similar baseline characteristics with the exception of elevated 
mean creatinine level in the CPB-CABG group (p<0.045). No difference was detected between the groups with respect to survival, transfusions, in-
hospital length of stay, neurologic or pulmonary complications. There was an appreciably higher incidence of renal failure requiring dialysis n the 
CPB-CABG cohort compared to OPCABG patients (p<0.025) despite a lower mean preoperative creatinine level in the CPB-CABG group (p<0.02).
Conclusions:  OPCABG is safe and feasible in low LVEF patients and provides a significant advantage in renal protection over CPB-CABG in this 
high-risk group.
 
